Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023

SHANGHAI, March 27, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines and vaccines, today announced its financial...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: ERN Source Type: news